REGIS, GABRIELLA

REGIS, GABRIELLA  

Struttura Didattica Speciale di Biotecnologie  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.01 secondi).
Titolo Data di pubblicazione Autore(i) File
Constitutive STAT3 activation in epidermal keratinocytes enhances cell clonogenicity and favors spontaneous immortalization by opposing differentiation and senescence checkpoints 2014 Valeria Orecchia;Gabriella Regis;Beatrice Tassone;Chiara Valenti;Lidia Avalle;Stefania Saoncella;Vincenzo Calautti;Valeria Poli
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes 2006 G. REGIS; L. CONTI; D. BOSELLI; F. NOVELLI
IGF-1 down-regulates IFN-gamma R2 chain surface expression and desensitizes IFN-gamma/STAT-1 signaling in human T lymphocytes. 2003 BERNABEI P; BOSTICARDO M; LOSANA G; REGIS G; DI PAOLA F; DE ANGELIS S; M. GIOVARELLI; NOVELLI F
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 2009 Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 2006 Regis G; Icardi L; Conti L; Chiarle R; Bernabei P; Poli V; Novelli F.
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 2007 CONTI L; REGIS G; LONGO A; BERNABEI P; CHIARLE R; GIOVARELLI M; NOVELLI F
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 2006 Conti L; Longo A; Regis G; Giovarelli M; Chiarle R; Novelli F.
Iron chelation restores human T cells sensitivity to the IFN-g/STAT1 signaling pathway. Jaks and Stats: development to disease 2004 Regis G; Bosticardo M; Conti L; De Angelis S; Bernabei P; Giovarelli M; Novelli F.
Iron regulates T lymphocyte sensitivity to the IFN-g/STAT1 signaling pathway in vitro and in vivo 2005 Regis G; Bosticardo M; Conti L; De Angelis S; Boselli D; Tomaino B; Bernabei P; Giovarelli M; Novelli F.
Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. 2005 REGIS G; BOSTICARDO M; CONTI L; DE ANGELIS S; BOSELLI D; TOMAINO B; BERNABEI P; GIOVARELLI M; NOVELLI F
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 2005 Conti L; Regis G; Longo A; Giovarelli M; Chiarle R; Novelli F.
STAT1 and STAT3 in tumorigenesis: A matter of balance 2012 Avalle L.; Pensa S.; Regis G.; Novelli F.; V Poli
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin? 2009 Pensa S; Regis G; Boselli D; Novelli F; Poli V
STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models. 2014 Marino F;Orecchia V;Regis G;Musteanu M;Tassone B;Jon C;Forni M;Calautti E;Chiarle R;Eferl R;Poli V
Universal and Specific Functions of STAT3in Solid Tumours 2012 Avalle L; Regis G; Poli V.
Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling 2008 Regis G; Pensa S; Boselli D; Novelli F; Poli V.